NEA Management Company’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$165K Hold
1,000,000
0.01% 26
2026
Q1
$329K Sell
1,000,000
-17,093,034
-94% -$26.9M 0.02% 25
2025
Q4
$56.1M Hold
18,093,034
2.86% 11
2025
Q3
$47.6M Hold
18,093,034
2.61% 14
2025
Q2
$22.3M Hold
18,093,034
1.68% 14
2025
Q1
$19.9M Hold
18,093,034
1.53% 14
2024
Q4
$16.4M Hold
18,093,034
0.92% 17
2024
Q3
$17.9M Hold
18,093,034
0.98% 19
2024
Q2
$16.3M Buy
18,093,034
+2,255,025
+14% +$1.69M 1.23% 19
2024
Q1
$18.7M Hold
15,838,009
1.16% 22
2023
Q4
$14.5M Buy
15,838,009
+110,067
+0.7% +$81.3K 0.96% 21
2023
Q3
$13.1M Buy
15,727,942
+12,260,536
+354% +$14.1M 1.01% 23
2023
Q2
$4.16M Hold
3,467,406
0.32% 35
2023
Q1
$4.37M Hold
3,467,406
0.3% 38
2022
Q4
$7.52M Hold
3,467,406
0.42% 33
2022
Q3
$41.5M Buy
+3,467,406
New +$43M 2.07% 14

Other funds holding GOSS

NEA Management Company's GOSS Position: Q2 2026 in Review

NEA Management Company held its Gossamer Bio (GOSS) position steady in Q2 2026 at 1,000,000 shares worth $165K. The position accounts for 0.01% of the portfolio, ranked #26.

NEA Management Company first reported a position in GOSS in Q3 2022 and has held it in 16 quarters since. The position peaked at $56.1M in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • NEA Management Company held 1,000,000 shares of Gossamer Bio worth $165K as of Q2 2026.
  • NEA Management Company left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up 0.01% of NEA Management Company's portfolio in Q2 2026, its #26 holding.
  • NEA Management Company first reported a position in Gossamer Bio in Q3 2022 and has held it in 16 quarters since.
  • NEA Management Company's Gossamer Bio position peaked at $56.1M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on NEA Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.